DKSH has entered a distribution agreement with Abcam, a global life science company working together with researchers to advance science and enable faster breakthroughs, in Vietnam.  This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market.

Vietnam – DKSH Business Unit Technology has announced its strategic collaboration with Abcam, a global life science company, to enhance the distribution and accessibility of the wide array of products designed to support life science research in Vietnam. Under the terms of the agreement, DKSH will extend its sales and marketing, application support, and after-sales services to cater to the market.

Driven by the purpose of efficiently enabling scientific breakthroughs by serving life scientists to achieve their mission faster, Abcam continuously provides its diverse range of highly validated antibodies, assays, and other research tools that are essential for studying critical biological pathways. Its products are widely used in drug discovery, diagnostics, and basic research, particularly in areas like cancer, neurological disorders, and infectious diseases. By leveraging DKSH’s extensive distribution network and market expertise, this partnership will streamline access to Abcam’s products for academia, laboratories, and research institutions across Vietnam.

Rich Lane, Commercial General Manager, JAPAC at Abcam stated: “Partnering with DKSH in Vietnam marks a strategic step in Abcam’s vision to become the most influential life sciences company for researchers worldwide. Utilizing DKSH’s profound expertise and strength in the life science industry, we are confident to keep innovating and enhancing our technical expertise and manufacturing capabilities to provide solutions that will enable scientific progress. DKSH’s team emerges as a pivotal partner for Abcam business growth in Vietnam.”

“We are thrilled to collaborate with Abcam to broaden our portfolio of life science products in Vietnam. With our robust marketing, sales, and application support capabilities, we are committed to supporting Abcam’s growth while meeting the diverse needs of researchers nationwide,” shared Macro Farina, Senior Director, Business Development & Center of Excellence, Business Unit Technology, DKSH.

About Abcam
Abcam believes that the scientific community goes further, faster, when all go there together. And to keep on making ground-breaking discoveries, all need to work together in new ways. That is why Abcam is constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. Abcam started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, the company helps 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. www.abcam.com

About DKSH
DKSH’s purpose is to enrich people’s lives. For almost 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 29,040 specialists, generating net sales of CHF 11.1 billion in 2023. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,760 specialists, the Business Unit generated net sales of CHF 532.6 million in 2023. www.dksh.com/tec